Detalles de la búsqueda
1.
[Guidelines for post-marketing research on clinical effectiveness of Chinese patent medicines].
Zhongguo Zhong Yao Za Zhi
; 49(3): 842-848, 2024 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-38621888
2.
[Thoughts of treatment of tumor diseases based on toxic pathogen theory].
Zhongguo Zhong Yao Za Zhi
; 48(5): 1413-1419, 2023 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-37005825
3.
[Technical points of human use experience of ethnic medicine].
Zhongguo Zhong Yao Za Zhi
; 48(5): 1402-1406, 2023 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-37005823
4.
[CiteSpace knowledge map of research hotspots and frontiers of Polygalae Radix].
Zhongguo Zhong Yao Za Zhi
; 48(6): 1664-1672, 2023 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-37005854
5.
[Guideline for clinical comprehensive evaluation of Chinese patent medicine (2022 version)].
Zhongguo Zhong Yao Za Zhi
; 48(1): 256-264, 2023 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-36725278
6.
[Clinical comprehensive evaluation of Chinese patent medicine based on EVIDEM].
Zhongguo Zhong Yao Za Zhi
; 47(10): 2833-2840, 2022 May.
Artículo
en Zh
| MEDLINE | ID: mdl-35718504
7.
[Category of Chinese medicine registration:historical evolution,current status,and problems].
Zhongguo Zhong Yao Za Zhi
; 47(2): 562-568, 2022 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-35179001
8.
[Expert consensus on human use experience research of traditional Chinese medicine].
Zhongguo Zhong Yao Za Zhi
; 47(18): 4829-4834, 2022 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-36164892
9.
[Relevant thoughts on development of traditional Chinese medicine industry in new era].
Zhongguo Zhong Yao Za Zhi
; 47(17): 4799-4813, 2022 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-36164887
10.
[Thoughts on path of R&D and registration of innovative traditional Chinese medicine with synchronous transformation of "series prescriptions"].
Zhongguo Zhong Yao Za Zhi
; 47(4): 1120-1125, 2022 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-35285213
11.
[Reflections on supervision strategies of new Tibetan drug registration].
Zhongguo Zhong Yao Za Zhi
; 47(19): 5383-5388, 2022 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-36472046
12.
[Research and development strategies of new Chinese medicines based on new regulations].
Zhongguo Zhong Yao Za Zhi
; 46(12): 3150-3155, 2021 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-34467707
13.
[Data collection, quality and evidence formation for human use experience of traditional Chinese medicine].
Zhongguo Zhong Yao Za Zhi
; 46(7): 1681-1685, 2021 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-33982468
14.
[Theoretical thinking on guiding research and development of new drugs of traditional Chinese medicine].
Zhongguo Zhong Yao Za Zhi
; 46(7): 1686-1690, 2021 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-33982469
15.
[Development of clinical trial of new drugs of traditional Chinese medicines].
Zhongguo Zhong Yao Za Zhi
; 46(7): 1691-1695, 2021 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-33982470
16.
[Expert consensus on key issues of quality control in clinical trials of new drugs of traditional Chinese medicine].
Zhongguo Zhong Yao Za Zhi
; 46(7): 1701-1705, 2021 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-33982472
17.
[Consensus on collaborative ethical review of multi-center clinical trials of new drugs of traditional Chinese medicine (version 1.0)].
Zhongguo Zhong Yao Za Zhi
; 46(7): 1696-1700, 2021 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-33982471
18.
[Thoughts and suggestions on registration and classification of traditional Chinese medicines].
Zhongguo Zhong Yao Za Zhi
; 45(16): 4004-4008, 2020 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-32893601
19.
[Suggestions on technical requirements for traditional Chinese medicine new drug research and development].
Zhongguo Zhong Yao Za Zhi
; 45(16): 4009-4016, 2020 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-32893602
20.
[Large- scale prospective clinical study on prophylactic intervention of COVID-19 in community population using Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules].
Zhongguo Zhong Yao Za Zhi
; 45(13): 2993-3000, 2020 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-32726003